November 6, 2019 8:40am
Economics skew the session: Weekly mortgage applications flat line for the second straight week
Earnings central: Athersys (ATHX), AxoGen (AXGN), Ionis Pharmaceuticals (IONS), Sangamo therapeutics (SGMO), Voyager therapeutics (VYGR), Caladrius Biosciences (CLBS) and Bellicum Pharmaceuticals (BLCM)
My version of the morning’s numbers is written to be informative than just about changes to fundamentals; it’s what happened or will beyond the headline and what could happen to the future
Ask yourself, do you know why you own it? What are the catalysts? What's the pipeline look like? Do you understand the CEO's vision and how many different “fallbacks” it has; so if one goes wrong it's not the end of the world?
Dow futures are UP +0.08% (+20 points), S&P futures are UP +0.06% (+2 points) and NASDAQ futures are +0.08% (+6points)
U.S. stock index futures slightly up on Wednesday morning after the Dow posted a fresh record close on Tuesday;
European markets traded mixed with the pan-European Stoxx 600 hovered just below the flat line in
Asia Pacific shares traded mixed with MSCI’s Asia-Pacific index excluding Japan edging slightly lower. Singapore’s Straits Times index led regional gains, adding 0.3%.early trade;
Data Docket: industrial productivity figures and unit labor costs data for the third quarter are due out at 9:30 a.m. ET.
Investors are waiting for signals on the trade dispute between the U.S. and China.
China is reportedly pressing U.S. President Trump to roll back tariffs the U.S. imposed in September before a “phase one” trade deal is signed between the world’s two biggest economies.
Interesting statement, “UN economists warned in a report on Tuesday that the Sino-U.S. trade war was a “lose-lose” situation, costing China $35 billion in the first half of this year while U.S. consumers and companies bore the brunt of the most expensive tariffs.”
Watch the dips pre the earnings release, focus on the LPS (loss-per-share) numbers compared to the last three (3) quarters, review the “runway’s” traction and measure the tone and reading ability of the CEO’s script (sarcasm) – they should talk to you not at you , it’s your, our or my investment!
Tuesday night’s newsletter heading: “the market stutters, the sector slips yet, closes with a positive Advance/Decline (A/D) line on the third session of November as volume continues on the low side, unsteadiness rules.”
- The NASDAQ closed UP +1.48 points (+0.02%);
- The IBB closed up +0.02% while the XBI closed flat at 0.00%;
- The close was positive with an A/D line of 23/17, 2 flats, 1 reversed merged (HSGX) and 2 acquired;
- The range of the 23 upside was +0.34% (ALNY) to +12.86% (VCEL) while the 17 downside ranged from -0.32% (ONVO) to -16.94% (CUR);
- 5 out of the 23 upside had higher than the 3 month average volume;
- 6 out of the 17 downside had higher than the 3 month average volume;
- November opened with 2 positive and 1 negative close
- October registered 10 positive, 1 neutral and 14 negative closes
- September, there were 1 holiday, 11 negative, 7 positive and 2 non reported sessions;
Companies in my headlights – It’s your decision; I provide an idea and context:
*** I can’t change my “tune” … be mindful of upcoming quarterly results and their effect upon share pricing … BUY and get trampled in the coming sessions or SELL into strength or just HOLD and wait to resolve relieve the earnings estimates and expectation anxiety.
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.